| 摘要 |
<p>There are disclosed immunogenic peptides from Anaplastic Lymphoma Kinase (ALK), methods in vivo or in vitro for activating ALK-specific CTLs (cytotoxic T-lymphocyte) and for stimulating an immune response against tumors, and pharmaceutical compositions containing ALK peptides for tumor immunotherapy.</p> |
